The first trial of an AI-powered chatbot designed to inform parents about the HPV vaccine has shown that it increases vaccine ...

The first trial of an AI (Artificial Intelligence)-powered chatbot designed to inform parents about the HPV vaccine has shown that it increases vaccine uptake and engagement with health professionals.

Investigators conducted a study to explore the determinants of HPV vaccine uptake among young women in the U.S. to help produce more effective interventions strategies.

Researchers are using virus-like particles to develop a safer, cheaper polio vaccine to help eradicate the disease once and for all.